Skip to main content
Fig. 2 | BMC Medical Genetics

Fig. 2

From: POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction

Fig. 2

Histologic grade, clinical stage, and POLE mutational status are independent prognostic factors for endometrial cancer patients. a Kaplan–Meier curve and log-rank test for endometrial cancer patients based on histologic grade classification. b Kaplan–Meier curve and log-rank test for endometrial cancer patients based on clinical stage classification. c Kaplan–Meier curve and log-rank test for endometrial cancer patients based on POLE mutational status classification

Back to article page